195 related articles for article (PubMed ID: 23803173)
1. Factors that might impact intrathecal drug delivery (IDD) dose escalation: a longitudinal study.
Mekhail N; Mahboobi R; Farajzadeh Deroee A; Costandi S; Dalton J; Guirguis M; Mehta P
Pain Pract; 2014 Apr; 14(4):301-8. PubMed ID: 23803173
[TBL] [Abstract][Full Text] [Related]
2. A predictive model for intrathecal opioid dose escalation for chronic non-cancer pain.
Duarte RV; Raphael JH; Haque MS; Southall JL; Ashford RL
Pain Physician; 2012; 15(5):363-9. PubMed ID: 22996848
[TBL] [Abstract][Full Text] [Related]
3. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients.
Veizi IE; Hayek SM; Narouze S; Pope JE; Mekhail N
Pain Med; 2011 Oct; 12(10):1481-9. PubMed ID: 21943351
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent intrathecal opioid escalation in chronic noncancer pain patients.
Hayek SM; Veizi IE; Narouze SN; Mekhail N
Pain Med; 2011 Aug; 12(8):1179-89. PubMed ID: 21810164
[TBL] [Abstract][Full Text] [Related]
5. Medical cost impact of intrathecal drug delivery for noncancer pain.
Guillemette S; Witzke S; Leier J; Hinnenthal J; Prager JP
Pain Med; 2013 Apr; 14(4):504-15. PubMed ID: 23480485
[TBL] [Abstract][Full Text] [Related]
6. Initial Intrathecal Dose Titration and Predictors of Early Dose Escalation in Patients With Cancer Using a 100:1 Oral to Intrathecal Morphine Conversion Ratio.
Sindt JE; Odell DW; Tariq R; Presson AP; Zhang C; Brogan SE
Neuromodulation; 2021 Oct; 24(7):1157-1166. PubMed ID: 34375481
[TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
8. Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center.
Engle MP; Vinh BP; Harun N; Koyyalagunta D
Pain Physician; 2013; 16(3):251-7. PubMed ID: 23703411
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up.
Atli A; Theodore BR; Turk DC; Loeser JD
Pain Med; 2010 Jul; 11(7):1010-6. PubMed ID: 20492572
[TBL] [Abstract][Full Text] [Related]
10. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
[TBL] [Abstract][Full Text] [Related]
11. Outcome of intrathecal opioids in chronic non-cancer pain.
Roberts LJ; Finch PM; Goucke CR; Price LM
Eur J Pain; 2001; 5(4):353-61. PubMed ID: 11743701
[TBL] [Abstract][Full Text] [Related]
12. Long-term use of intrathecal droperidol as an excellent antiemetic in nonmalignant pain--a retrospective study.
Ahmad-Sabry MH; Shareghi G
Middle East J Anaesthesiol; 2012 Oct; 21(6):857-62. PubMed ID: 23634568
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management.
Zin CS; Nissen LM; O'Callaghan JP; Moore BJ; Smith MT
Pain Med; 2010 Apr; 11(4):550-61. PubMed ID: 20202139
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.
Hamza M; Doleys D; Wells M; Weisbein J; Hoff J; Martin M; Soteropoulos C; Barreto J; Deschner S; Ketchum J
Pain Med; 2012 Oct; 13(10):1304-13. PubMed ID: 22845187
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study.
Du Pen S; Du Pen A; Hillyer J
Pain Med; 2006; 7(1):10-5. PubMed ID: 16533191
[TBL] [Abstract][Full Text] [Related]
16. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
Grider JS; Harned ME; Etscheidt MA
Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477
[TBL] [Abstract][Full Text] [Related]
17. Long-term intraspinal infusions of opioids with a new implantable medication pump.
Likar R; Spendel MC; Amberger W; Kepplinger B; Supanz S; Sadjak A
Arzneimittelforschung; 1999 Jun; 49(6):489-93. PubMed ID: 10417863
[TBL] [Abstract][Full Text] [Related]
18. Continuous intrathecal clonidine administration for the treatment of neuropathic pain.
Uhle EI; Becker R; Gatscher S; Bertalanffy H
Stereotact Funct Neurosurg; 2000; 75(4):167-75. PubMed ID: 11910210
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal analgesia.
Cohen SP; Dragovich A
Med Clin North Am; 2007 Mar; 91(2):251-70. PubMed ID: 17321285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
